AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 155 filers reported holding AMNEAL PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $221 | +268.3% | 52,455 | +21.2% | 0.00% | +200.0% |
| Q1 2023 | $60 | -100.0% | 43,282 | -30.5% | 0.00% | -50.0% |
| Q3 2022 | $126,000 | +70.3% | 62,243 | +300.4% | 0.00% | – |
| Q4 2021 | $74,000 | -64.6% | 15,547 | -60.3% | 0.00% | -100.0% |
| Q3 2021 | $209,000 | +80.2% | 39,120 | +127.8% | 0.00% | 0.0% |
| Q1 2021 | $116,000 | +34.9% | 17,170 | -9.0% | 0.00% | – |
| Q4 2020 | $86,000 | -68.8% | 18,876 | -67.4% | 0.00% | -100.0% |
| Q2 2020 | $276,000 | +93.0% | 57,907 | +40.6% | 0.00% | +100.0% |
| Q1 2020 | $143,000 | +95.9% | 41,196 | +170.6% | 0.00% | 0.0% |
| Q4 2019 | $73,000 | +135.5% | 15,224 | +40.4% | 0.00% | – |
| Q3 2019 | $31,000 | -98.4% | 10,844 | -95.9% | 0.00% | -100.0% |
| Q2 2019 | $1,906,000 | +892.7% | 265,834 | +1776.4% | 0.01% | +550.0% |
| Q4 2018 | $192,000 | +60.0% | 14,167 | +93.0% | 0.00% | +100.0% |
| Q2 2018 | $120,000 | – | 7,342 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 21,521,301 | $83,503,000 | 7.34% |
| Eversept Partners, LP | 2,656,208 | $10,306,087 | 2.29% |
| TPG Group Holdings (SBS) Advisors, Inc. | 16,213,367 | $62,908,000 | 1.13% |
| Prosight Management, LP | 512,659 | $1,989,000 | 0.95% |
| THB ASSET MANAGEMENT | 833,104 | $3,232,000 | 0.90% |
| GLOBEFLEX CAPITAL L P | 251,696 | $977,000 | 0.26% |
| XTX MARKETS LLC | 10,243 | $40,000 | 0.19% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 102,000 | $396,000 | 0.10% |
| PA Capital LLC | 33,874 | $132,000 | 0.09% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 60,900 | $236,000 | 0.07% |